Hormone Replacement Therapy after Cervical Cancer with Jason Wright

IJGC Podcast - A podcast by BMJ Group - Mondays

In this rebroadcast episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Dr. Jason Wright to discuss hormone replacement therapy after cervical cancer. Dr. Wright is the Sol Goldman Associate Professor and Chief of the Division of Gynecologic Oncology at Columbia University.   Highlights: -Among cervical cancer patients <50 years of age who underwent surgery including oophorectomy or primary radiation, only 39% received estrogen replacement therapy. -In patients who did receive estrogen replacement therapy the duration of use was short, with a median of only 60 days. -Black patients were significantly less likely to receive estrogen replacement therapy than White patients.